• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用生物标志物、认知能力和人格特质绘制阿尔茨海默病的神经精神症状:一项系统综述

Mapping the Neuropsychiatric Symptoms in Alzheimer's Disease Using Biomarkers, Cognitive Abilities, and Personality Traits: A Systematic Review.

作者信息

Chatzikostopoulos Athanasios, Moraitou Despina, Papaliagkas Vasileios, Tsolaki Magda

机构信息

Laboratory of Psychology, Department of Cognition, Brain and Behavior, School of Psychology, Faculty of Philosophy, Aristotle University of Thessaloniki (AUTh), 54124 Thessaloniki, Greece.

Laboratory of Neurodegenerative Diseases, Center of Interdisciplinary Research and Innovation (CIRI-AUTH), Balcan Center, Buildings A & B, 57001 Thessaloniki, Greece.

出版信息

Diagnostics (Basel). 2025 Apr 24;15(9):1082. doi: 10.3390/diagnostics15091082.

DOI:10.3390/diagnostics15091082
PMID:40361900
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12072134/
Abstract

Symptoms (NPS) in Alzheimer's disease (AD) have multiple effects in daily living, not only for the patients but for their caregivers too. The present systematic review was performed in order to identify if biomarkers, cognitive functions, and personality traits can be considered as important factors for the development and maintenance of these symptoms. To achieve that, the existing literature spanning the period from 2018 to 2024 was critically analyzed. To be included in the review, a study had to investigate any of the factors mentioned above. In total, 182 articles were assessed for eligibility, and 50 met the inclusion criteria. Most of the studies were focused on the role of biomarkers and found that amyloid β, tau and phospho-tau protein are closely related to the incidence and the severity of NPS. In fewer studies, cognitive function and personality traits were also associated with NPS. In conclusion, biomarkers, cognitive function and personality traits are associated with NPS, but the underlying mechanisms, still, mostly remain unknown.

摘要

阿尔茨海默病(AD)中的症状(神经精神症状,NPS)对日常生活有多种影响,不仅对患者如此,对其照料者也是如此。进行本系统综述是为了确定生物标志物、认知功能和人格特质是否可被视为这些症状发生和维持的重要因素。为实现这一目的,对2018年至2024年期间的现有文献进行了批判性分析。要纳入该综述,一项研究必须调查上述任何一个因素。总共评估了182篇文章的 eligibility,其中50篇符合纳入标准。大多数研究聚焦于生物标志物的作用,发现淀粉样β蛋白、tau蛋白和磷酸化tau蛋白与神经精神症状的发生率和严重程度密切相关。在较少的研究中,认知功能和人格特质也与神经精神症状有关。总之,生物标志物、认知功能和人格特质与神经精神症状有关,但潜在机制大多仍不明。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff64/12072134/fafb0bf3af59/diagnostics-15-01082-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff64/12072134/fafb0bf3af59/diagnostics-15-01082-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff64/12072134/fafb0bf3af59/diagnostics-15-01082-g001.jpg

相似文献

1
Mapping the Neuropsychiatric Symptoms in Alzheimer's Disease Using Biomarkers, Cognitive Abilities, and Personality Traits: A Systematic Review.利用生物标志物、认知能力和人格特质绘制阿尔茨海默病的神经精神症状:一项系统综述
Diagnostics (Basel). 2025 Apr 24;15(9):1082. doi: 10.3390/diagnostics15091082.
2
Amyloid and Tau Pathology Associations With Personality Traits, Neuropsychiatric Symptoms, and Cognitive Lifestyle in the Preclinical Phases of Sporadic and Autosomal Dominant Alzheimer's Disease.淀粉样蛋白和 Tau 病理学与散发性和常染色体显性阿尔茨海默病临床前阶段的人格特质、神经精神症状和认知生活方式的关联。
Biol Psychiatry. 2021 Apr 15;89(8):776-785. doi: 10.1016/j.biopsych.2020.01.023. Epub 2020 Feb 6.
3
Cerebrospinal Fluid Correlates of Neuropsychiatric Symptoms in Patients with Alzheimer's Disease/Mild Cognitive Impairment: A Systematic Review.阿尔茨海默病/轻度认知障碍患者神经精神症状的脑脊液相关性:系统评价。
J Alzheimers Dis. 2019;71(2):477-501. doi: 10.3233/JAD-190365.
4
Prediction of cognitive decline in healthy aging based on neuropsychiatric symptoms and PET-biomarkers of Alzheimer's disease.基于神经精神症状和阿尔茨海默病的 PET 生物标志物预测健康老龄化中的认知能力下降。
J Neurol. 2024 Apr;271(4):2067-2077. doi: 10.1007/s00415-023-12131-0. Epub 2023 Dec 19.
5
Cognition Mediates the Association Between Cerebrospinal Fluid Biomarkers of Amyloid and P-Tau and Neuropsychiatric Symptoms.认知功能在脑脊液淀粉样蛋白和磷酸化 tau 生物标志物与神经精神症状之间的关联中起中介作用。
J Alzheimers Dis. 2024;100(3):1055-1073. doi: 10.3233/JAD-240125.
6
Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer's disease and cognitively unimpaired individuals.淀粉样蛋白前体(AT(N))生物标志物与临床前阿尔茨海默病及认知正常个体神经精神症状的相关性。
Transl Neurodegener. 2021 Mar 31;10(1):11. doi: 10.1186/s40035-021-00236-3.
7
Neuropsychiatric Symptoms and In Vivo Alzheimer's Biomarkers in Mild Cognitive Impairment.轻度认知障碍中的神经精神症状与体内阿尔茨海默病生物标志物
J Alzheimers Dis. 2023;96(4):1827-1836. doi: 10.3233/JAD-220835.
8
Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression.血浆神经丝轻链、胶质纤维酸性蛋白和磷酸化 tau181 作为神经精神症状和相关临床疾病进展的生物标志物。
Alzheimers Res Ther. 2024 Jul 25;16(1):165. doi: 10.1186/s13195-024-01526-4.
9
Neuropsychiatric Symptoms and Commonly Used Biomarkers of Alzheimer's Disease: A Literature Review from a Machine Learning Perspective.神经精神症状和阿尔茨海默病常用生物标志物:从机器学习角度的文献综述。
J Alzheimers Dis. 2023;92(4):1131-1146. doi: 10.3233/JAD-221261.
10
Tau as a biomarker of cognitive impairment and neuropsychiatric symptom in Alzheimer's disease.tau 作为阿尔茨海默病认知障碍和神经精神症状的生物标志物。
Hum Brain Mapp. 2023 Feb 1;44(2):327-340. doi: 10.1002/hbm.26043. Epub 2022 Aug 14.

本文引用的文献

1
Linking cognitive and behavioral reserve: Evidence from the CAN-PROTECT study.连接认知储备与行为储备:来自CAN - PROTECT研究的证据。
Alzheimers Dement (N Y). 2024 Oct 4;10(4):e12497. doi: 10.1002/trc2.12497. eCollection 2024 Oct.
2
Neuropsychiatric symptoms: Risk factor or disease marker? A study of structural imaging biomarkers of Alzheimer's disease and incident cognitive decline.神经精神症状:风险因素还是疾病标志物?一项关于阿尔茨海默病结构影像学生物标志物与认知能力下降发生率的研究。
Hum Brain Mapp. 2024 Sep;45(13):e70016. doi: 10.1002/hbm.70016.
3
Locus coeruleus integrity and neuropsychiatric symptoms in a cohort of early- and late-onset Alzheimer's disease.
蓝斑核完整性与早发性和晚发性阿尔茨海默病队列的神经精神症状。
Alzheimers Dement. 2024 Sep;20(9):6351-6364. doi: 10.1002/alz.14131. Epub 2024 Jul 25.
4
Cognition Mediates the Association Between Cerebrospinal Fluid Biomarkers of Amyloid and P-Tau and Neuropsychiatric Symptoms.认知功能在脑脊液淀粉样蛋白和磷酸化 tau 生物标志物与神经精神症状之间的关联中起中介作用。
J Alzheimers Dis. 2024;100(3):1055-1073. doi: 10.3233/JAD-240125.
5
Difference of Cerebrospinal Fluid Biomarkers and Neuropsychiatric Symptoms Profiles among Normal Cognition, Mild Cognitive Impairment, and Dementia Patient.正常认知、轻度认知障碍和痴呆患者的脑脊液生物标志物和神经精神症状特征的差异。
Int J Mol Sci. 2024 Mar 31;25(7):3919. doi: 10.3390/ijms25073919.
6
Revised Temperament and Character Inventory factors predict neuropsychiatric symptoms and aging-related cognitive decline across 25 years.修订后的气质与性格量表因素可预测25年间的神经精神症状及与衰老相关的认知衰退。
Front Aging Neurosci. 2024 Feb 21;16:1335336. doi: 10.3389/fnagi.2024.1335336. eCollection 2024.
7
Study Partner Report of Apathy in Older Adults is Associated with AD Biomarkers: Findings from the Harvard Aging Brain Study.老年人淡漠研究报告与 AD 生物标志物相关:哈佛老龄化大脑研究的结果。
Am J Geriatr Psychiatry. 2024 Aug;32(8):909-919. doi: 10.1016/j.jagp.2024.01.020. Epub 2024 Jan 28.
8
Clinical and neuroimaging association between neuropsychiatric symptoms and nutritional status across the Alzheimer's disease continuum: a longitudinal cohort study.阿尔茨海默病连续体中神经精神症状与营养状况之间的临床及神经影像学关联:一项纵向队列研究
J Nutr Health Aging. 2024 Mar;28(3):100182. doi: 10.1016/j.jnha.2024.100182. Epub 2024 Feb 9.
9
Neuropsychiatric symptoms in Alzheimer's continuum and their association with plasma biomarkers.阿尔茨海默病连续谱中的神经精神症状及其与血浆生物标志物的关系。
J Affect Disord. 2024 Mar 1;348:200-206. doi: 10.1016/j.jad.2023.12.062. Epub 2023 Dec 29.
10
Prediction of cognitive decline in healthy aging based on neuropsychiatric symptoms and PET-biomarkers of Alzheimer's disease.基于神经精神症状和阿尔茨海默病的 PET 生物标志物预测健康老龄化中的认知能力下降。
J Neurol. 2024 Apr;271(4):2067-2077. doi: 10.1007/s00415-023-12131-0. Epub 2023 Dec 19.